| Literature DB >> 23326479 |
Patricia M Cano1, Julie Seeboth, François Meurens, Juliette Cognie, Roberta Abrami, Isabelle P Oswald, Laurence Guzylack-Piriou.
Abstract
BACKGROUND/AIMS: Deoxynivalenol (DON) is a mycotoxin produced by Fusarium species which is commonly found in temperate regions worldwide as a natural contaminant of cereals. It is of great concern not only in terms of economic losses but also in terms of animal and public health. The digestive tract is the first and main target of this food contaminant and it represents a major site of immune tolerance. A finely tuned cross-talk between the innate and the adaptive immune systems ensures the homeostatic equilibrium between the mucosal immune system and commensal microorganisms. The aim of this study was to analyze the impact of DON on the intestinal immune response.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23326479 PMCID: PMC3542340 DOI: 10.1371/journal.pone.0053647
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
List of genes, primers sequences (F: Forward; R: Reverse) and accession numbers and references.
| Gene Symbol | Gene name | Primer sequence | References |
| IL1-α | Interleukin 1 - alpha | F: | NC_010445.3 |
| R: | |||
| IL1-β | Interleukin 1 - beta | F: | NM_001005149 |
| R: | |||
| TNF-α | Tumor necrosis factor - alpha | F: | NM_214022 |
| R: |
| ||
| IL6 | Interleukin 6 | F: | NM_214399 |
| R: |
| ||
| IL8 | Interleukin 8 | F: | NM_213867 |
| R: |
| ||
| IL10 | Interleukin 10 | F: | NM_214041 |
| R: |
| ||
| IL12-p40 | Interleukin 12 p40 | F: | NM_214013 |
| R: | |||
| IL17α | Interleukin 17 - alpha | F: | AB102693 |
| R: |
| ||
| IL21 | Interleukin 21 | F : | MN_214415 |
| R: |
| ||
| IL22 | Interleukin 22 | F: | AY937228 |
| R: |
| ||
| IL23A | Interleukin 23 - alpha | F: |
|
| R: | |||
| TGF-β | Transforming growth factor - beta | F: | X54859 |
| R: |
| ||
| CCL20/MIP3 alpha | Chemokine (CCL20) | F: | NM_001024589 |
| R: |
| ||
| IFN-γ | Interferon - gamma | F: | NM_213948 |
| R: |
| ||
| ROR-γ like | Nuclear receptor ROR-gamma-like | F: | NC_010446.3 |
| R: | |||
| FoxP3 | Forkhead box P3 | F: | AY669812 |
| R: |
| ||
| CX3CL1/Fractalkine | Chemokine (CX3CL1) | F: | EST CK464144 |
| R: |
| ||
| XCR1 | Chemokine (XCR1) | F: |
|
| R: | |||
| CCR6 | Chemokine (CCR6) | F: |
|
| R: | |||
| STAT3 | Signal transducer and activator of transcription 3 | F: | MN_001044580 |
| R: |
| ||
| RALDH1 | Retinaldehyde deshydrogenase 1 | F: | N–010460–3 |
| R: |
| ||
| T-bet | T-cell beta chain Th17-Th22 like | F: | Present study |
| R: | |||
| Cyclo A | Cyclophilin A | F: | MN_214353 |
| R: |
| ||
| RPL32 | Ribosomal Protein L32 | F: | MN_001001636 |
| R: |
|
Figure 1Deoxynivalenol induced cytokines and chemokines mRNA relative expression (A) and protein concentration (B) in IPEC-1 cells
.
Figure 2Deoxynivalenol up-regulated pro-inflammatory cytokines (A) and DCs-recruiting chemokines mRNA relative expression (B) in jejunal explants.
Figure 3Deoxynivalenol increased IL-12 but not IFN-γ gene expression in jejunal explants.
Figure 4Deoxynivalenol triggered Th17 response in jejunal explants.
Figure 5Deoxynivalenol decreased T regulatory response in jejunal explants.
Figure 6Deoxynivalenol triggered pathogenic Th17 cells subset but not regulatory Th17 (rTh17) cells in porcine jejunal explants.